 |
|
|
|
 |
- A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with B cell Lymphoid Malignancies
Barker, Juliet, MBBS
[Protocol 06-066]
- A Phase I Study of Beta-Glucan and Rituximab in Children and Adolescents with Relapsed CD20-Positive Lymphoma or Leukemia or Post-Transplant Lymphoproliferative Disease
Modak, Shakeel, MD
[Protocol 03-095]
- A Phase I Study of CYT 107 in Recipients of HLA-Matched T Cell-Depleted Peripheral Blood Stem Cell or Bone Marrow Transplants
Van Den Brink, Marcel, MD, PhD
[Protocol 07-127]
- A Phase I Study of Clofarabine Plus Topotecan, Vinorelbine, Thiotepa, and Dexamethasone in Pediatric Patients with Relapsed or Refractory Acute Leukemia
Steinherz, Peter, MD
[Protocol 07-012]
- A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation
O'Reilly, Richard, MD
[Protocol 07-055]
- A Phase I/II Study of the Toxic and Therapeutic Effects of T Cells in the Treatment of Epstein Barr Virus-Associated Lymphoproliferative Disorders
O'Reilly, Richard, MD
[Protocol 95-024]
- A Phase I/II Trial of Clofarabine, Melphalan, and Thiotepa Followed by an Allogeneic Stem Cell Transplant for the Treatment of High-Risk and/or Advanced Hematologic Malignancies
Boulad, Farid, MD
[Protocol 06-125]
- A Phase II Study of Peri-transplant Palifermin followed by an Allogeneic T-Cell-Depleted Stem Cell Transplant in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved from MDS
Castro-Malaspina, Hugo, MD
[Protocol 08-008]
- A Phase II Trial of Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplants after a Myeloablative Preparative Regimen for Adult Patients with Lymphohematopoietic Disorders
Jakubowski, Ann, MD, PhD
[Protocol 01-070]
- A Phase II Trial of HLA Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Leukemia Following Allogeneic Hematopoietic Stem Cell Transplant
Hsu, Katharine, MD, PhD
[Protocol 07-035]
- Cyclophosphamide, Fludarabine, and Total Body Irradiation Followed by the Transplantation of Unrelated Double-Unit Donor Umbilical Cord Blood Grafts for Patients with Hematological Malignancy
Barker, Juliet, MBBS
[Protocol 06-014]
- Participation in the National Marrow Donor Program Registry
Kernan, Nancy, MD
[Protocol 90-091]
Last Updated: Mar. 9, 2006
|
|
|
|
|
